Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

ClinicalTrials.gov ID: NCT07497880

Public ClinicalTrials.gov record NCT07497880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 8:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to determine the efficacy of oral KAI-7535 once daily compared with placebo on percent change in body weight in participants living with obesity or overweight, with at least 1 weight-related comorbidity, without diabetes mellitus. Safety and tolerability and other weight-related outcomes will also be evaluated.

Study identification

NCT ID
NCT07497880
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kailera
Industry
Enrollment
306 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 5, 2026
Primary completion
Jul 6, 2027
Completion
Jul 6, 2027
Last update posted
Sep 8, 2026

2026 – 2027

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
28
Facility City State ZIP Site status
Kailera Clinical Site Chandler Arizona 85225
Kailera Clinical Site Phoenix Arizona 85044
Kailera Clinical Site Irvine California 92614
Kailera Clinical Site Lincoln California 95648
Kailera Clinical Site Northridge California 91325
Kailera Clinical Site Hamden Connecticut 06517
Kailera Clinical Site Jacksonville Florida 32256
Kailera Clinical Site Jupiter Florida 33458
Kailera Clinical Site Palm Springs Florida 33461
Kailera Clinical Site Pembroke Pines Florida 33024
Kailera Clinical Site Decatur Georgia 30030
Kailera Clinical Site Chicago Illinois 60640
Kailera Clinical Site Skokie Illinois 60077
Kailera Clinical Site South Bend Indiana 46617
Kailera Clinical Site Kenner Louisiana 70065
Kailera Clinical Site Garden City Michigan 48135
Kailera Clinical Site Jefferson City Missouri 65109
Kailera Clinical Site Kansas City Missouri 64151
Kailera Clinical Site Spartanburg South Carolina 29303
Kailera Clinical Site Knoxville Tennessee 37909
Kailera Clinical Site Austin Texas 78705
Kailera Clinical Site Austin Texas 78757
Kailera Clinical Site Brownsville Texas 78520
Kailera Clinical Site Farmers Branch Texas 75234
Kailera Clinical Site Fort Worth Texas 76135
Kailera Clinical Site Mesquite Texas 75149
Kailera Clinical Site San Antonio Texas 78222
Kailera Clinical Site San Antonio Texas 78229
Kailera Clinical Site San Antonio Texas 78240
Kailera Clinical Site Sugar Land Texas 77479
Kailera Clinical Site Sandy City Utah 84093

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07497880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2026 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07497880 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →